Outcomes of Radiotherapy in the First-Line Treatment of Recurrent/Metastatic Cervical Cancer: A Multicenter, Retrospective Study

被引：0
|
作者：
Peng, C. [1 ]
Li, X. [1 ]
Tang, W. [1 ]
Guo, Q. [1 ]
Wu, Q. [1 ]
Xie, P. [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1086
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [41] Prognostic analysis of PD-1/CTLA-4 bispecific antibody combined with chemotherapy first-line treatment for recurrent or metastatic cervical cancer: A multicenter real-world study
    Li, Jiwei
    Wu, Tao
    Deng, Yuping
    Xu, Chao
    Jiang, Yupeng, Sr.
    Zou, Wen
    Feng, Yeqian
    Wu, Lin
    Wang, Jingjing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Multicenter phase II trial of S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable colorectal cancer
    Shin, S.
    Park, Y.
    Kim, T.
    Oh, D.
    Shim, B.
    Lee, K.
    Lee, M.
    Kim, Y.
    Kim, Y.
    Ahn, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)
    Yang, Yunpeng
    Pan, Jianji
    Wang, Hui
    Zhao, Yuanyuan
    Qu, Shenhong
    Chen, Nianyong
    Chen, Xiaozhong
    Sun, Yan
    He, Xiaohui
    Hu, Chaosu
    Lin, Lizhu
    Yu, Qitao
    Wang, Siyang
    Wang, Guihua
    Lei, Feng
    Wen, Jiyu
    Yang, Kunyu
    Lin, Zhixiong
    Guo, Ye
    Chen, Shaoqing
    Huang, Xiaoming
    Wu, Yanjie
    Liang, Liang
    Chen, Chenqi
    Bai, Fan
    Ma, Xiaopeng
    Zhang, Yun
    Leaw, Shiangjiin
    Zhang, Li
    Fang, Wenfeng
    CANCER CELL, 2023, 41 (06) : 1061 - +
  • [44] Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study
    Demirci, Nebi Serkan
    Aksoy, Sercan
    Ozdemir, Nuriye Yildirim
    Erdem, Gokmen Umut
    Ozcelik, Melike
    Tanrikulu, Eda
    Eren, Tulay
    Bozkaya, Yakup
    Sahin, Suleyman
    Basol, Fatma
    Aslan, Suheyla Aytac
    Zengin, Nurullah
    Gullu, Ibrahim
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (03) : 401 - 407
  • [45] Combined taxane, platinum, and cetuximab as a first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma: Retrospective study
    Liu, Yizhen
    Xue, Liqiong
    Xia, Zuguang
    Zhang, Qunling
    Guo, Ye
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (09): : 2040 - 2045
  • [46] A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Morine, Yuji
    Watanabe, Kazuo
    Ueno, Makoto
    Ioka, Tatsuya
    Kanai, Masashi
    Kondo, Shunsuke
    Okano, Naohiro
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (01) : 76 - 85
  • [47] The Efficacy And Safety Of Apatinib Treatment For Patients With Metastatic Or Recurrent Cervical Cancer: A Retrospective Study
    Yu, Jiangtao
    Xu, Ziwen
    Li, Anyang
    Zhang, Jindi
    Wang, Yi
    Zhao, Hongqin
    Zhu, Haiyan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 3419 - 3424
  • [48] Phase II Multicenter Study of Docetaxel and Bevacizumab With or Without Trastuzumab as First-Line Treatment for Patients With Metastatic Breast Cancer
    Schwartzberg, Lee S.
    Badarinath, Suprith
    Keaton, Mark R.
    Childs, Barrett H.
    CLINICAL BREAST CANCER, 2014, 14 (03) : 161 - 168
  • [49] A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
    Naminatsu Takahara
    Yousuke Nakai
    Hiroyuki Isayama
    Takashi Sasaki
    Yuji Morine
    Kazuo Watanabe
    Makoto Ueno
    Tatsuya Ioka
    Masashi Kanai
    Shunsuke Kondo
    Naohiro Okano
    Kazuhiko Koike
    Investigational New Drugs, 2023, 41 : 76 - 85
  • [50] Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia
    Yi, Jun Ho
    Yi, Seong Yoon
    Lee, Hye Ran
    Lee, Soon Il
    Lim, Do Hyoung
    Kim, Jung Han
    Park, Keon Woo
    Lee, Jeeyun
    MELANOMA RESEARCH, 2011, 21 (03) : 223 - 227
12345